As of 2025-12-05, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (8.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 70.01 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -112.5%.
The range of the Relative Valuation is (6.30) - (11.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 14.3x | 9.8x |
| Forward P/E multiples | 7.6x - 15.1x | 11.4x |
| Fair Price | (6.30) - (11.88) | (8.74) |
| Upside | -109.0% - -117.0% | -112.5% |
| Date | P/E |
| 2025-12-03 | -85.67 |
| 2025-12-02 | -84.33 |
| 2025-12-01 | -84.48 |
| 2025-11-28 | -88.15 |
| 2025-11-26 | -88.25 |
| 2025-11-25 | -86.60 |
| 2025-11-24 | -87.13 |
| 2025-11-21 | -85.64 |
| 2025-11-20 | -83.46 |
| 2025-11-19 | -85.00 |
| 2025-11-18 | -87.11 |
| 2025-11-17 | -87.14 |
| 2025-11-14 | -86.21 |
| 2025-11-13 | -83.57 |
| 2025-11-12 | -85.41 |
| 2025-11-11 | -86.06 |
| 2025-11-10 | -84.12 |
| 2025-11-07 | -82.19 |
| 2025-11-06 | -81.72 |
| 2025-11-05 | -84.58 |
| 2025-11-04 | -85.64 |
| 2025-11-03 | -85.50 |
| 2025-10-31 | -87.67 |
| 2025-10-30 | -87.13 |
| 2025-10-29 | -85.03 |
| 2025-10-28 | -85.09 |
| 2025-10-27 | -86.38 |
| 2025-10-24 | -84.50 |
| 2025-10-23 | -83.76 |
| 2025-10-22 | -83.99 |
| 2025-10-21 | -83.24 |
| 2025-10-20 | -88.13 |
| 2025-10-17 | -88.73 |
| 2025-10-16 | -89.81 |
| 2025-10-15 | -91.94 |
| 2025-10-14 | -88.43 |
| 2025-10-13 | -87.09 |
| 2025-10-10 | -87.74 |
| 2025-10-09 | -89.08 |
| 2025-10-08 | -87.91 |
| 2025-10-07 | -88.98 |
| 2025-10-06 | -87.52 |
| 2025-10-03 | -88.03 |
| 2025-10-02 | -86.58 |
| 2025-10-01 | -88.09 |
| 2025-09-30 | -88.47 |
| 2025-09-29 | -87.91 |
| 2025-09-26 | -87.80 |
| 2025-09-25 | -88.78 |
| 2025-09-24 | -89.61 |